Lodenafil – (139755-85-4)

Lodenafil, also known as hydroxyhomosildenafil, is a PDE5 inhibitor used for treating erectile dysfunction. It is formulated as a prodrug, lodenafil carbonate, which breaks down in the body to release two active lodenafil molecules, offering higher oral bioavailability.

Lodenafil has undergone Phase III clinical trials but is not yet approved by the U.S. FDA. It belongs to the same class as sildenafil, tadalafil, and vardenafil, with a chemical.

The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Sources:

https://en.wikipedia.org/wiki/Lodenafil
https://www.medchemexpress.com/lodenafil.html
https://www.medkoo.com/products/15860
https://www.sciencedirect.com/topics/medicine-and-dentistry/lodenafil